Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
Status:
Unknown status
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
The study is an investigator-sponsored, prospective, multicenter, randomized, open-label
study designed to compare efficacy and safety between bivalirudin and heparin in elderly
patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.
Phase:
Phase 4
Details
Lead Sponsor:
The First Affiliated Hospital of Dalian Medical University